All the MDSC-DCs vaccines treated mice had significantly increased frequency of tumor-infiltrating CD8+T cells, particularly CD24+MDSC-DCs, compared with PBS-treated control (Fig. 3BandSupplementary Fig. S4B[available in the online version only]). This evidence concerns the gene CD24 and neoplasm.